APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nasal Spray Vaccine

Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza.

The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray.

Selected research

Market Analysis & Forecast

Global Nasal Spray Vaccine Market Analysis and Forecast 2026-2032

30 December 2025197 pages

Choose your research edition.

Industry ResearchNasal Spray Vaccine Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Nasal Spray Vaccine Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Nasal Spray Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nasal Spray Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Nasal Spray Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza.

The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray.

Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal Spray Vaccine is for Adult, and the consumption proportion is about 68% in 2019.

Read the full market overview

Europe is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Europe, North America is the second largest consumption place.

Market competition is intense. AstraZeneca, Cipla, BCHT the leaders of the industry, and hold key technologies, with high-end customers, they are also the main international exporters. However, with further expanding market, there will be more manufactures in the future.

Europe is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Europe, North America is the second largest consumption place.

Market competition is intense. AstraZeneca, Cipla, BCHT the leaders of the industry, and hold key technologies, with high-end customers, they are also the main international exporters. However, with further expanding market, there will be more manufactures in the future.

This report presents an overview of global market for Nasal Spray Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nasal Spray Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Nasal Spray Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nasal Spray Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nasal Spray Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nasal Spray Vaccine sales, projected growth trends, production technology, application and end-user industry.

Nasal Spray Vaccine Segment by Company

AstraZeneca FLUMIST

Cipla

BCHT

Nasal Spray Vaccine Segment by Type

Child Nasal Spray Vaccine

Adult Nasal Spray Vaccine

Nasal Spray Vaccine Segment by Application

Child

Adult

Nasal Spray Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Spray Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Spray Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Spray Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nasal Spray Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nasal Spray Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nasal Spray Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nasal Spray Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Child Nasal Spray Vaccine Major Manufacturers Table 3. Adult Nasal Spray Vaccine Major Manufacturers Table 4. Global Nasal Spray Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Child Major Manufacturers Table 6. Adult Major Manufacturers Table 7. Nasal Spray Vaccine Industry Trends Table 8. Nasal Spray Vaccine Industry Drivers Table 9. Nasal Spray Vaccine Industry Opportunities and Challenges Table 10. Nasal Spray Vaccine Industry Restraints Table 11. Global Nasal Spray Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Nasal Spray Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Nasal Spray Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Nasal Spray Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Nasal Spray Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Nasal Spray Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Dose) Table 17. Global Nasal Spray Vaccine Sales by Region (2021-2026) & (K Dose) Table 18. Global Nasal Spray Vaccine Sales by Region (2027-2032) & (K Dose) Table 19. Global Nasal Spray Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Nasal Spray Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Nasal Spray Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Nasal Spray Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Nasal Spray Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Nasal Spray Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Nasal Spray Vaccine Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 26. Global Nasal Spray Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Nasal Spray Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Nasal Spray Vaccine Manufacturers, Product Type & Application Table 29. Global Nasal Spray Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Nasal Spray Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Nasal Spray Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Nasal Spray Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Nasal Spray Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Nasal Spray Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Nasal Spray Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Nasal Spray Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Dose) Table 38. Global Nasal Spray Vaccine Sales by Type (2021-2026) & (K Dose) Table 39. Global Nasal Spray Vaccine Sales by Type (2027-2032) & (K Dose) Table 40. Global Nasal Spray Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Nasal Spray Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Nasal Spray Vaccine Price by Type (2021-2026) & (US$/Dose) Table 43. Global Nasal Spray Vaccine Price by Type (2027-2032) & (US$/Dose) Table 44. Global Nasal Spray Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Nasal Spray Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Nasal Spray Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Nasal Spray Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Nasal Spray Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Nasal Spray Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Dose) Table 50. Global Nasal Spray Vaccine Sales by Application (2021-2026) & (K Dose) Table 51. Global Nasal Spray Vaccine Sales by Application (2027-2032) & (K Dose) Table 52. Global Nasal Spray Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Nasal Spray Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Nasal Spray Vaccine Price by Application (2021-2026) & (US$/Dose) Table 55. Global Nasal Spray Vaccine Price by Application (2027-2032) & (US$/Dose) Table 56. AstraZeneca FLUMIST Company Information Table 57. AstraZeneca FLUMIST Business Overview Table 58. AstraZeneca FLUMIST Nasal Spray Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 59. AstraZeneca FLUMIST Nasal Spray Vaccine Product Portfolio Table 60. AstraZeneca FLUMIST Recent Development Table 61. Cipla Company Information Table 62. Cipla Business Overview Table 63. Cipla Nasal Spray Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 64. Cipla Nasal Spray Vaccine Product Portfolio Table 65. Cipla Recent Development Table 66. BCHT Company Information Table 67. BCHT Business Overview Table 68. BCHT Nasal Spray Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 69. BCHT Nasal Spray Vaccine Product Portfolio Table 70. BCHT Recent Development Table 71. North America Nasal Spray Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 72. North America Nasal Spray Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 73. North America Nasal Spray Vaccine Sales by Type (2021-2026) & (K Dose) Table 74. North America Nasal Spray Vaccine Sales by Type (2027-2032) & (K Dose) Table 75. North America Nasal Spray Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 76. North America Nasal Spray Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 77. North America Nasal Spray Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Nasal Spray Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Nasal Spray Vaccine Sales by Application (2021-2026) & (K Dose) Table 80. North America Nasal Spray Vaccine Sales by Application (2027-2032) & (K Dose) Table 81. North America Nasal Spray Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 82. North America Nasal Spray Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 83. North America Nasal Spray Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. North America Nasal Spray Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 85. North America Nasal Spray Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 86. North America Nasal Spray Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 87. North America Nasal Spray Vaccine Sales by Country (2021-2026) & (K Dose) Table 88. North America Nasal Spray Vaccine Sales by Country (2027-2032) & (K Dose) Table 89. North America Nasal Spray Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 90. North America Nasal Spray Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 91. United States Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 92. Canada Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 93. Mexico Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 94. Europe Nasal Spray Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Nasal Spray Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Nasal Spray Vaccine Sales by Type (2021-2026) & (K Dose) Table 97. Europe Nasal Spray Vaccine Sales by Type (2027-2032) & (K Dose) Table 98. Europe Nasal Spray Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 99. Europe Nasal Spray Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 100. Europe Nasal Spray Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Nasal Spray Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Nasal Spray Vaccine Sales by Application (2021-2026) & (K Dose) Table 103. Europe Nasal Spray Vaccine Sales by Application (2027-2032) & (K Dose) Table 104. Europe Nasal Spray Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 105. Europe Nasal Spray Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 106. Europe Nasal Spray Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Nasal Spray Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. Europe Nasal Spray Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. Europe Nasal Spray Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 110. Europe Nasal Spray Vaccine Sales by Country (2021-2026) & (K Dose) Table 111. Europe Nasal Spray Vaccine Sales by Country (2027-2032) & (K Dose) Table 112. Europe Nasal Spray Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 113. Europe Nasal Spray Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 114. Germany Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 115. France Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 116. U.K. Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 117. Italy Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 118. Russia Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 119. Spain Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 120. Netherlands Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 121. Switzerland Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 122. Sweden Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 123. Poland Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 124. China Nasal Spray Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 125. China Nasal Spray Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 126. China Nasal Spray Vaccine Sales by Type (2021-2026) & (K Dose) Table 127. China Nasal Spray Vaccine Sales by Type (2027-2032) & (K Dose) Table 128. China Nasal Spray Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 129. China Nasal Spray Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 130. China Nasal Spray Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 131. China Nasal Spray Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 132. China Nasal Spray Vaccine Sales by Application (2021-2026) & (K Dose) Table 133. China Nasal Spray Vaccine Sales by Application (2027-2032) & (K Dose) Table 134. China Nasal Spray Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 135. China Nasal Spray Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 136. Asia Nasal Spray Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Nasal Spray Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Nasal Spray Vaccine Sales by Type (2021-2026) & (K Dose) Table 139. Asia Nasal Spray Vaccine Sales by Type (2027-2032) & (K Dose) Table 140. Asia Nasal Spray Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 141. Asia Nasal Spray Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 142. Asia Nasal Spray Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Nasal Spray Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Nasal Spray Vaccine Sales by Application (2021-2026) & (K Dose) Table 145. Asia Nasal Spray Vaccine Sales by Application (2027-2032) & (K Dose) Table 146. Asia Nasal Spray Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 147. Asia Nasal Spray Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 148. Asia Nasal Spray Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Nasal Spray Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Asia Nasal Spray Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Asia Nasal Spray Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 152. Asia Nasal Spray Vaccine Sales by Country (2021-2026) & (K Dose) Table 153. Asia Nasal Spray Vaccine Sales by Country (2027-2032) & (K Dose) Table 154. Asia Nasal Spray Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 155. Asia Nasal Spray Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 156. Japan Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 157. South Korea Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 158. India Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 159. Australia Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 160. Taiwan Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 161. Southeast Asia Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 162. SAMEA Nasal Spray Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA Nasal Spray Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA Nasal Spray Vaccine Sales by Type (2021-2026) & (K Dose) Table 165. SAMEA Nasal Spray Vaccine Sales by Type (2027-2032) & (K Dose) Table 166. SAMEA Nasal Spray Vaccine Sales Price by Type (2021-2026) & (US$/Dose) Table 167. SAMEA Nasal Spray Vaccine Sales Price by Type (2027-2032) & (US$/Dose) Table 168. SAMEA Nasal Spray Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 169. SAMEA Nasal Spray Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 170. SAMEA Nasal Spray Vaccine Sales by Application (2021-2026) & (K Dose) Table 171. SAMEA Nasal Spray Vaccine Sales by Application (2027-2032) & (K Dose) Table 172. SAMEA Nasal Spray Vaccine Sales Price by Application (2021-2026) & (US$/Dose) Table 173. SAMEA Nasal Spray Vaccine Sales Price by Application (2027-2032) & (US$/Dose) Table 174. SAMEA Nasal Spray Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. SAMEA Nasal Spray Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. SAMEA Nasal Spray Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. SAMEA Nasal Spray Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 178. SAMEA Nasal Spray Vaccine Sales by Country (2021-2026) & (K Dose) Table 179. SAMEA Nasal Spray Vaccine Sales by Country (2027-2032) & (K Dose) Table 180. SAMEA Nasal Spray Vaccine Sales Price by Country (2021-2026) & (US$/Dose) Table 181. SAMEA Nasal Spray Vaccine Sales Price by Country (2027-2032) & (US$/Dose) Table 182. Brazil Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 183. Argentina Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Chile Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Colombia Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Peru Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 187. Saudi Arabia Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 188. Israel Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 189. UAE Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 190. Turkey Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Iran Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 192. Egypt Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Nasal Spray Vaccine Distributors List Table 196. Nasal Spray Vaccine Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Nasal Spray Vaccine Image Figure 2. Global Nasal Spray Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nasal Spray Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Child Nasal Spray Vaccine Image Figure 5. Adult Nasal Spray Vaccine Image Figure 6. Global Nasal Spray Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Nasal Spray Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Child Image Figure 9. Adult Image Figure 10. Global Nasal Spray Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Nasal Spray Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Nasal Spray Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Nasal Spray Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Nasal Spray Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Nasal Spray Vaccine Sales (2021-2032) & (K Dose) Figure 16. Global Nasal Spray Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Dose) Figure 17. Global Nasal Spray Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Nasal Spray Vaccine Sales YoY (2021-2032) & (K Dose) Figure 19. Europe Nasal Spray Vaccine Sales YoY (2021-2032) & (K Dose) Figure 20. China Nasal Spray Vaccine Sales YoY (2021-2032) & (K Dose) Figure 21. Asia (Excluding China) Nasal Spray Vaccine Sales YoY (2021-2032) & (K Dose) Figure 22. South America, Middle East and Africa Nasal Spray Vaccine Sales YoY (2021-2032) & (K Dose) Figure 23. Global Nasal Spray Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Nasal Spray Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Nasal Spray Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Nasal Spray Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Nasal Spray Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Nasal Spray Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Dose) Figure 30. Global Nasal Spray Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Nasal Spray Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Nasal Spray Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Nasal Spray Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Nasal Spray Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Nasal Spray Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Dose) Figure 36. Global Nasal Spray Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Nasal Spray Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Nasal Spray Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Nasal Spray Vaccine Sales Share by Type (2021-2032) Figure 40. North America Nasal Spray Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Nasal Spray Vaccine Sales Share by Application (2021-2032) Figure 42. North America Nasal Spray Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Nasal Spray Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Nasal Spray Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Nasal Spray Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Nasal Spray Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Nasal Spray Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Nasal Spray Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Nasal Spray Vaccine Sales Share by Country (2021-2032) Figure 50. China Nasal Spray Vaccine Revenue Share by Type (2021-2032) Figure 51. China Nasal Spray Vaccine Sales Share by Type (2021-2032) Figure 52. China Nasal Spray Vaccine Revenue Share by Application (2021-2032) Figure 53. China Nasal Spray Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Nasal Spray Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Nasal Spray Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Nasal Spray Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Nasal Spray Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Nasal Spray Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Nasal Spray Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Nasal Spray Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Nasal Spray Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Nasal Spray Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Nasal Spray Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Nasal Spray Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Nasal Spray Vaccine Sales Share by Country (2021-2032) Figure 66. Nasal Spray Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Nasal Spray Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Child Nasal Spray Vaccine
  • Adult Nasal Spray Vaccine
Applications
  • Child
  • Adult
Companies covered
  • AstraZeneca FLUMIST
  • Cipla
  • BCHT

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nasal Spray Vaccine Market by Type
  3. 1.2.1 Global Nasal Spray Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Child Nasal Spray Vaccine
  5. 1.2.3 Adult Nasal Spray Vaccine
  6. 1.3 Nasal Spray Vaccine Market by Application
  7. 1.3.1 Global Nasal Spray Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Child
  9. 1.3.3 Adult
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Nasal Spray Vaccine Market Dynamics
  1. 2.1 Nasal Spray Vaccine Industry Trends
  2. 2.2 Nasal Spray Vaccine Industry Drivers
  3. 2.3 Nasal Spray Vaccine Industry Opportunities and Challenges
  4. 2.4 Nasal Spray Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nasal Spray Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nasal Spray Vaccine Revenue by Region
  3. 3.2.1 Global Nasal Spray Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nasal Spray Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Nasal Spray Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Nasal Spray Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nasal Spray Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nasal Spray Vaccine Sales by Region
  9. 3.4.1 Global Nasal Spray Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nasal Spray Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Nasal Spray Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Nasal Spray Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nasal Spray Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Nasal Spray Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nasal Spray Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nasal Spray Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nasal Spray Vaccine Sales by Manufacturers
  6. 4.2.1 Global Nasal Spray Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nasal Spray Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nasal Spray Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nasal Spray Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nasal Spray Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nasal Spray Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nasal Spray Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Nasal Spray Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nasal Spray Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Nasal Spray Vaccine Tier 1, Tier 2, and Tier 3
5 Nasal Spray Vaccine Market by Type
  1. 5.1 Global Nasal Spray Vaccine Revenue by Type
  2. 5.1.1 Global Nasal Spray Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nasal Spray Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nasal Spray Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nasal Spray Vaccine Sales by Type
  6. 5.2.1 Global Nasal Spray Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nasal Spray Vaccine Sales by Type (2021-2032) & (K Dose)
  8. 5.2.3 Global Nasal Spray Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nasal Spray Vaccine Price by Type
6 Nasal Spray Vaccine Market by Application
  1. 6.1 Global Nasal Spray Vaccine Revenue by Application
  2. 6.1.1 Global Nasal Spray Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nasal Spray Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nasal Spray Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nasal Spray Vaccine Sales by Application
  6. 6.2.1 Global Nasal Spray Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nasal Spray Vaccine Sales by Application (2021-2032) & (K Dose)
  8. 6.2.3 Global Nasal Spray Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nasal Spray Vaccine Price by Application
7 Company Profiles
  1. 7.1 AstraZeneca FLUMIST
  2. 7.1.1 AstraZeneca FLUMIST Company Information
  3. 7.1.2 AstraZeneca FLUMIST Business Overview
  4. 7.1.3 AstraZeneca FLUMIST Nasal Spray Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca FLUMIST Nasal Spray Vaccine Product Portfolio
  6. 7.1.5 AstraZeneca FLUMIST Recent Developments
  7. 7.2 Cipla
  8. 7.2.1 Cipla Company Information
  9. 7.2.2 Cipla Business Overview
  10. 7.2.3 Cipla Nasal Spray Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Cipla Nasal Spray Vaccine Product Portfolio
  12. 7.2.5 Cipla Recent Developments
  13. 7.3 BCHT
  14. 7.3.1 BCHT Company Information
  15. 7.3.2 BCHT Business Overview
  16. 7.3.3 BCHT Nasal Spray Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 BCHT Nasal Spray Vaccine Product Portfolio
  18. 7.3.5 BCHT Recent Developments
8 North America
  1. 8.1 North America Nasal Spray Vaccine Market Size by Type
  2. 8.1.1 North America Nasal Spray Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Nasal Spray Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Nasal Spray Vaccine Price by Type (2021-2032)
  5. 8.2 North America Nasal Spray Vaccine Market Size by Application
  6. 8.2.1 North America Nasal Spray Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Nasal Spray Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Nasal Spray Vaccine Price by Application (2021-2032)
  9. 8.3 North America Nasal Spray Vaccine Market Size by Country
  10. 8.3.1 North America Nasal Spray Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nasal Spray Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nasal Spray Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Nasal Spray Vaccine Market Size by Type
  2. 9.1.1 Europe Nasal Spray Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nasal Spray Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Nasal Spray Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Nasal Spray Vaccine Market Size by Application
  6. 9.2.1 Europe Nasal Spray Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nasal Spray Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Nasal Spray Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Nasal Spray Vaccine Market Size by Country
  10. 9.3.1 Europe Nasal Spray Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nasal Spray Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nasal Spray Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Nasal Spray Vaccine Market Size by Type
  2. 10.1.1 China Nasal Spray Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Nasal Spray Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Nasal Spray Vaccine Price by Type (2021-2032)
  5. 10.2 China Nasal Spray Vaccine Market Size by Application
  6. 10.2.1 China Nasal Spray Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Nasal Spray Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Nasal Spray Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nasal Spray Vaccine Market Size by Type
  2. 11.1.1 Asia Nasal Spray Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nasal Spray Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Nasal Spray Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Nasal Spray Vaccine Market Size by Application
  6. 11.2.1 Asia Nasal Spray Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nasal Spray Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Nasal Spray Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Nasal Spray Vaccine Market Size by Country
  10. 11.3.1 Asia Nasal Spray Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nasal Spray Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nasal Spray Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nasal Spray Vaccine Market Size by Type
  2. 12.1.1 SAMEA Nasal Spray Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nasal Spray Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nasal Spray Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Nasal Spray Vaccine Market Size by Application
  6. 12.2.1 SAMEA Nasal Spray Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nasal Spray Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nasal Spray Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Nasal Spray Vaccine Market Size by Country
  10. 12.3.1 SAMEA Nasal Spray Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nasal Spray Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nasal Spray Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nasal Spray Vaccine Value Chain Analysis
  2. 13.1.1 Nasal Spray Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nasal Spray Vaccine Production Mode & Process
  6. 13.2 Nasal Spray Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nasal Spray Vaccine Distributors
  9. 13.2.3 Nasal Spray Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst